Posts Tagged: drug development


IP Protection Critical for BioPharma Given Number, Cost and Complexity of Clinical Trials

Biopharmaceutical innovation is difficult, expensive, time-consuming, and risky. More so now than ever. A 2014 study by Tufts University’s Center for the Study of Drug Development calculated …

Will More Regulation Create Cheaper Drugs?

The idea of reducing drug prices through more government control is always simmering on the backburner and doesn’t require much to bring it to a full …
By Joseph Allen
4 years ago 12

The Need for Regulatory Data Protection in the TPP: Why Australia’s Got it All Wrong

While patents protect innovations that are novel, nonobvious and useful, data exclusivity protects the extensive preclinical and clinical trial data required to establish new therapies as safe …

What ‘The Economist’ Doesn’t Get About Patents

In what can only be characterized as a bizarre, rambling, and intellectually dishonest article, 'The Economist' has inexplicably taken the position that patents are not necessary for …
By Gene Quinn
4 years ago 35

The looming patent nightmare facing the pharmaceutical industry

During the last hearing of the House Judiciary Committee there was an attempt to insert language via amendment that would make it impossible for Kyle Bass and …
By Gene Quinn
4 years ago 17

Bristol-Myers, AstraZeneca and AmGen maintain strong new drug pipelines

There’s been a lot of positive activity in recent months for Bristol-Myers Squibb of New York City. In early March, the U.S. Food and Drug …
By Steve Brachmann
5 years ago 1

Bayh-Dole Forecast: Sunny with 20% chance of Shark Attack

How tragic if the United States of America turns its patent system into a tool that rich and powerful companies use to suppress innovation that challenges their …
By Joseph Allen
5 years ago 1

Why is the Cystic Fibrosis Foundation under attack for funding the drug of the year?

Cystic fibrosis creates a thick, sticky mucus that builds up in the airways, causing infections, and making it difficult to breathe. Chronic pain is a common problem …
By Joseph Allen
5 years ago 8

Around and Around We Go: The Drug Development Debate

Every once and a while we get a clear example of the gulf between those battling over important public policy issues and can understand why the public …
By Joseph Allen
5 years ago 4

When Lives Depend on Tech Transfer

Nothing clarified the stakes in orphan drug development like hearing Ron Bartek describe how after 16 years a promising treatment for his son’s disease finally emerged with …
By Joseph Allen
5 years ago 0

The High Cost of Making Pharmaceuticals

It is nearly universally accepted (and for a reason) that the process from discovery to market is long and costly. Drugs to not invent themselves and there …

Patents are Just the Start

Capitol Hill is frequently the setting for both grandstanding and pandering, and given the prevailing political and public sentiment it is also frequently a place where businesses …

Patents, Drugs and the Moral High Ground

There are millions and millions of people dying each year from all kinds of illnesses that are easily preventable using simple technologies and drugs that are off …
By Gene Quinn
6 years ago 9

Hunting Bayh-Dole Vampires

The government is funding basic research at universities, not drug development. Bayh-Dole allows schools to own resulting inventions and license them for commercialization. These discoveries are more …
By Joseph Allen
6 years ago 1